Showing 1,459 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Janssen Submits Marketing Authorisation Application for Darunavir-Based Single Tablet Regimen for Treatment of HIV-1 to European Medicines Agency

Editor's pick
Janssen-Cilag press release
13 September 2016
Hepatitis B

ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B

Editor's pick
ContraVir press release
12 September 2016
Pharmaceutical industry

Drug firm boss who raised price of HIV medicine trolls Hillary Clinton after collapse at 9/11 memorial service

Editor's pick
Mirror.co.uk
12 September 2016
TB treatment

WHO launches Target Regimen Profiles for TB treatment

Editor's pick
World Health Organization
8 September 2016
Access to healthcare

Letter to Gilead Sciences on attempts to remove generic sofosbuvir from Ukraine

Editor's pick
MSF
7 September 2016
Access to healthcare

Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine

Editor's pick
STAT
7 September 2016
Access to healthcare

Ukraine's medicine bill slashed by 25% after UK firm brought in to handle procurement

Editor's pick
The Guardian
1 September 2016
Pharmaceutical industry

University of Minnesota sues Gilead Sciences over hepatitis drugs

Editor's pick
Minneapolis Star Tribune
31 August 2016
Pharmaceutical industry

Glaxo Bets It Can Shake Up HIV Treatment

Editor's pick
Wall Street Journal
30 August 2016
Pharmaceutical industry

Gilead Ignored HIV Groups Before Failed Bid To Have PrEP Subsidised In Australia

Editor's pick
BuzzFeed
25 August 2016
Pharmaceutical industry

Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

Editor's pick
UPI.com
19 August 2016
Pharmaceutical industry

German agency criticises European programme for speeding some drug approvals

Editor's pick
STAT
18 August 2016
Pharmaceutical industry

Cancer drug companies cut prices to win NHS approval

Editor's pick
The Guardian
18 August 2016
New & experimental HIV treatments

ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment

Editor's pick
ViiV press release
16 August 2016
Pharmaceutical industry

Gilead bags Genmab tech to develop bispecific antibody against HIV

Editor's pick
FierceBiotech
12 August 2016
HIV prevention policy

As EU Approval Moves Closer Are Governments Prepared For PrEP?

Editor's pick
Seeking Alpha
27 July 2016
Access to healthcare

South Africa: Produce HIV Drugs Locally, Says Science Minister

Editor's pick
AllAfrica
22 July 2016
PrEP

HIV Drug Pricing Protest Interrupts PrEP Session at AIDS 2016

Editor's pick
BETA blog
21 July 2016
Testing & health monitoring

Challenges Loom for Point-of-Care Diagnostics

Editor's pick
Genetic Engineering & Biotechnology News
13 July 2016
Pharmaceutical industry

Gilead defeats AIDS activists who claimed the company manipulated patents

Editor's pick
STAT
13 July 2016
Access to healthcare

The Medicines Patent Pool Signs New Round of Generic Manufacturing Licences for HIV and Hepatitis C Treatments

Editor's pick
Medicines Patent Pool
11 July 2016
Pharmaceutical industry

Gilead’s new price hikes on HIV drugs anger AIDS activists

Editor's pick
STAT
6 July 2016
Pharmaceutical industry

How To Avoid Black Market HIV Drugs

Editor's pick
HIV Plus
4 July 2016
Pharmaceutical industry

Brexit spells upheaval for EU and UK drug regulation

Editor's pick
Reuters
30 June 2016